Cargando…
A Management Algorithm for Mitomycin C Induced Cystitis
Background/Objective: A post-bladder tumor resection dose of MMC can reduce non-invasive papillary (pTa) bladder cancer recurrences by up to 40%; this treatment is recommended in both the AUA and EUA non-muscle-invasive bladder cancer guidelines. A common complication of this treatment is eosinophil...
Autores principales: | Luckenbaugh, Amy N., Marks, Rory M., Miller, David C., Weizer, Alon Z., Stoffel, John T., Montgomery, Jeffrey S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5409048/ https://www.ncbi.nlm.nih.gov/pubmed/28516158 http://dx.doi.org/10.3233/BLC-160089 |
Ejemplares similares
-
Role of biochemical markers in testicular cancer: diagnosis, staging, and surveillance
por: Milose, Jaclyn C, et al.
Publicado: (2011) -
Postoperative Bleb Management with Topical Mitomycin-C
por: Jonas, Jost B
Publicado: (2011) -
Cystitis
por: Dowd, J. Henry
Publicado: (1904) -
Cystitis
por: Ballenger, E. G.
Publicado: (1905) -
Cystitis
por: Murphy, C. E.
Publicado: (1892)